EP3433349B1 - Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices - Google Patents
Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices Download PDFInfo
- Publication number
- EP3433349B1 EP3433349B1 EP17716972.9A EP17716972A EP3433349B1 EP 3433349 B1 EP3433349 B1 EP 3433349B1 EP 17716972 A EP17716972 A EP 17716972A EP 3433349 B1 EP3433349 B1 EP 3433349B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- detergent composition
- composition
- fact
- total weight
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 99
- 239000003599 detergent Substances 0.000 title claims description 48
- 238000004140 cleaning Methods 0.000 title claims description 20
- 230000002255 enzymatic effect Effects 0.000 title description 12
- 239000004382 Amylase Substances 0.000 claims description 19
- 102000013142 Amylases Human genes 0.000 claims description 19
- 108010065511 Amylases Proteins 0.000 claims description 19
- 235000019418 amylase Nutrition 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000004367 Lipase Substances 0.000 claims description 16
- 102000004882 Lipase Human genes 0.000 claims description 16
- 108090001060 Lipase Proteins 0.000 claims description 16
- 235000019421 lipase Nutrition 0.000 claims description 16
- 108090000787 Subtilisin Proteins 0.000 claims description 15
- 239000002738 chelating agent Substances 0.000 claims description 15
- CIEZZGWIJBXOTE-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]propanoic acid Chemical compound OC(=O)C(C)N(CC(O)=O)CC(O)=O CIEZZGWIJBXOTE-UHFFFAOYSA-N 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 229940080260 iminodisuccinate Drugs 0.000 claims description 9
- PQHYOGIRXOKOEJ-UHFFFAOYSA-N 2-(1,2-dicarboxyethylamino)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)NC(C(O)=O)CC(O)=O PQHYOGIRXOKOEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002736 nonionic surfactant Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 238000012360 testing method Methods 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 229920002527 Glycogen Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 229960001484 edetic acid Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 102000008100 Human Serum Albumin Human genes 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- -1 alkylene glycols Chemical class 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 150000002191 fatty alcohols Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- JMHWNJGXUIJPKG-UHFFFAOYSA-N CC(=O)O[SiH](CC=C)OC(C)=O Chemical compound CC(=O)O[SiH](CC=C)OC(C)=O JMHWNJGXUIJPKG-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003165 hydrotropic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229940046305 5-bromo-5-nitro-1,3-dioxane Drugs 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 230000010736 Chelating Activity Effects 0.000 description 1
- 229920005682 EO-PO block copolymer Polymers 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 231100001260 reprotoxic Toxicity 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 229940080258 tetrasodium iminodisuccinate Drugs 0.000 description 1
- GYBINGQBXROMRS-UHFFFAOYSA-J tetrasodium;2-(1,2-dicarboxylatoethylamino)butanedioate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CC(C([O-])=O)NC(C([O-])=O)CC([O-])=O GYBINGQBXROMRS-UHFFFAOYSA-J 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M toluenesulfonate group Chemical group C=1(C(=CC=CC1)S(=O)(=O)[O-])C LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- GDJZZWYLFXAGFH-UHFFFAOYSA-M xylenesulfonate group Chemical group C1(C(C=CC=C1)C)(C)S(=O)(=O)[O-] GDJZZWYLFXAGFH-UHFFFAOYSA-M 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38627—Preparations containing enzymes, e.g. protease or amylase containing lipase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/26—Organic compounds containing nitrogen
- C11D3/33—Amino carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/32—Organic compounds containing nitrogen
- C11D7/3245—Aminoacids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/14—Hard surfaces
- C11D2111/20—Industrial or commercial equipment, e.g. reactors, tubes or engines
Definitions
- the present invention relates to the use of enzymatic detergent compositions for the automatic cleaning of surgical and / or medical instruments and / or apparatus.
- Dr. Weigert has developed the neodisher® SYSTEM ALPHA which is composed of two distinct highly concentrated components, namely an enzymatic component, the neodisher® SystemAct, and an alkaline component, the neodisher® SystemClean.
- the enzyme component contains a subtilisin while the alkaline component contains triethanolamine and methylglycine diacetic acid (MGDA).
- MGDA methylglycine diacetic acid
- the patent US 7,723,281 describes a detergent composition comprising a stabilized enzyme system.
- This enzymatic system comprises at least one enzyme but may include several, such as a protease, an amylase, a lipase, a gluconase, a cellulase, a peroxidase or a mixture thereof, as well as a chelating agent.
- the stabilizing effect is obtained by incorporating an amine, in particular an antimicrobial, and an acid in a specific molar ratio.
- the concentrated aqueous detergent composition of the invention does not present the problems of enzymatic stability encountered in the enzymatic compositions of the prior art containing alkanolamines.
- the tri-enzymatic cocktail of the concentrated aqueous detergent composition of the invention will simultaneously hydrolyze the three targets and thus facilitate detergency.
- the absence of alkanolamine makes it possible to formulate the detergent composition used in accordance with the invention in a very concentrated manner.
- the water content of the concentrated aqueous detergent composition can be reduced up to 25% by weight relative to the total weight of the composition without having to add significant amounts of third-solvent, impact the stability of the enzymes and harm cleaning efficiency.
- the composition used in accordance with the invention advantageously has a subtilisin content of 0.5 to 15% by weight relative to the total weight of the composition, preferably from 1 to 10% by weight relative to the total weight of the composition, preferably from 1 to 5% by weight relative to the total weight of the composition, more preferably around 3% by weight. relative to the total weight of the composition.
- the lipase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.
- the amylase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.
- the biodegradable chelating agent is chosen from methylglycine diacetic acid (MGDA) and an iminodisuccinate (IDS), in particular the tetrasodium iminodisuccinate.
- the biodegradable chelating agent is methylglycine diacetic acid (MGDA).
- MGDA methylglycine diacetic acid
- the chelating agent used in the present invention is not only used for softening water but also for complexing in a particularly effective way metal ions bi- and trivalent, in particular Ca 2+ , Fe 3+ , Fe 2+ and Cu 2+ , contained in the protein residues typically found on surgical and / or medical instruments. These chelating agents seem to sequester these metal ions, which destabilizes the tertiary structure of proteins and makes them more easily hydrolyzable.
- the composition used in accordance with the invention advantageously has a content of biodegradable chelating agent of 10 to 50% by weight relative to the total weight of the composition, preferably from 20 to 40% by weight relative to the total weight of the composition, more preferably from 25 to 35% by weight relative to the total weight of the composition, more preferably still around 30% by weight relative to the total weight of the composition.
- the concentrated aqueous detergent composition is advantageously free from any non-biodegradable chelating agent, in particular ethylene-diamine-tetraacetic acid (EDTA), diethylene-triamine-pentaacetic acid. (DTPA), phosphates and polyphosphates.
- EDTA ethylene-diamine-tetraacetic acid
- DTPA diethylene-triamine-pentaacetic acid
- phosphates diethylene-triamine-pentaacetic acid.
- polyphosphates phosphates
- the concentrated aqueous detergent composition is also free from any chelating agent classified as reprotoxic such as nitrilotriacetic acid and its sodium salt (NTA).
- the concentrated aqueous detergent composition is also free from alkali and alkaline earth hydroxides.
- the water content of the concentrated detergent composition used in accordance with the invention is advantageously from 10 to 50% by weight relative to the total weight of the composition, preferably from 15 to 45% by weight relative to the total weight of the composition , more preferably from 20 to 40% by weight relative to the total weight of the composition and more preferably still from 25 to 40% by weight relative to the total weight of the composition.
- the concentrated detergent composition may also contain a third solvent such as a polyol.
- suitable polyols include alkylene glycols such as ethylene glycol, propylene glycol and glycerin (1,2,3-propanetriol).
- the third solvent is glycerin.
- Glycerin has the advantage of not only serving as a third solvent but also of stabilizing the enzymes.
- the content of third-solvent is advantageously from 5 to 50% by weight relative to the total weight of the composition, preferably from 10 to 40% by weight relative to the total weight of the composition, more preferably from 13 to 25% by weight. weight relative to the total weight of the composition.
- the concentrated detergent composition used in accordance with the invention may also comprise one or more nonionic surfactants.
- the nonionic surfactant (s) may in particular be chosen from alkoxylated nonionic surfactants and alkylpolyglucosides.
- the alkoxylated nonionic surfactants are advantageously chosen from alkoxylated nonionic surfactants, in particular from alkoxylated fatty alcohols, in particular ethoxylated and / or propoxylated, and EO-PO block copolymers.
- the nonionic surfactant (s) are chosen from alkylpolyglucosides, preferably it is a C7 alkylpolyglucoside. This alkylpolyglucoside indeed brings the triple advantage of playing a stabilizing role, of bringing a wetting effect favorable to detergency and a non-foaming character compatible with an application in washer-disinfector.
- the content of nonionic surfactant in the detergent composition used in accordance with the invention is advantageously from 1 to 10%, preferably from 2 to 5%, more preferably from approximately 3% by weight relative to the total weight of the composition.
- the detergent composition used in accordance with the invention may further comprise an acid or a buffer system for adjusting the pH.
- an organic acid is added, chosen from C 2 -C 6 mono-, di- and tricarboxylic acids, especially chosen from citric acid, tartaric acid, malic acid, lactic acid, glutaric acid, gluconic acid glycolic acid, succinic acid and adipic acid.
- Citric acid is particularly preferred. It has the advantage of serving at the same time as a complexing agent such as tartaric acid and gluconic acid.
- the composition will not contain an antimicrobial agent, in particular no antimicrobial amine, and will therefore have no claim for antimicrobial activity at the dose of use. This is to be distinguished from a bacteriostatic effect which on the other hand can be sought.
- the detergent composition used in accordance with the invention may also comprise a preservative.
- the preservative can be chosen from the preservatives usually used, such as for example 5-chloro-5-methyl-4-isothiazoline-3-one, 2-methyl-4-isothiazolin3-one, p- acid hydroxybenzoic acid and its methyl esters, 5-bromo-5-nitro-1,3-dioxane and salicylic acid, benzyl alcohol and sodium benzoate.
- the detergent composition used in accordance with the invention may also comprise a hydrotropic agent.
- This hydrotropic agent can for example be chosen from xylenesulfonates, toluenesulfonates, cumenesulfonates, urea, methylacetamide, polyethylene glycol and polypropylene glycol.
- the concentrated detergent composition used in accordance with the invention may also comprise other adjuvants such as, for example, dispersing agents and / or anti-foaming agents.
- the dispersing agents can for example be acids of homo-, co- or terpolymers based on acrylic acid or alkali metal salts thereof (polyacrylates).
- the detergent composition is used in a washer-disinfector (LD) such as a washer-disinfector of instruments (LDI) or a washer-disinfector of endoscope (LDE).
- LD washer-disinfector
- LDE washer-disinfector of endoscope
- the term "washer-disinfector” should be understood as defined in standard ISO 15883-1: 2006, namely a machine intended for cleaning and disinfecting medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary.
- surgical and / or medical instruments as used in the present application is to be understood broadly as designating medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary environments requiring cleaning. with aqueous detergents before reuse.
- this cleaning is advantageously carried out at a temperature of 20 to 60 ° C., preferably from 45 to 55 ° C., more preferably from 50 to 55 ° C.
- the cleaning time is advantageously between 20 s and 10 min, preferably between 30 s and 5 min.
- the present invention also relates to the concentrated aqueous detergent composition used in the use according to the invention as described above.
- This composition is to be diluted with water, preferably softened, demineralized or osmosis, before use.
- the dilution is generally from 0.03% to 1% (v / v), preferably from 0.1% to 0.6% (v / v), more preferably from 0.2 to 0.4% (v / v) .
- the pH of the ready-to-use diluted composition is advantageously from 8 to 11, preferably from 8.5 to 9.5, more preferably from 8.8 to 9.2 and even more preferably from approximately 9.
- softened water is used (degree of hardness of approximately 5 ° f).
- compositions C1, C2 and C3 give completely satisfactory results under the test conditions. The best results are however obtained with composition C1. With this composition, we do not detect any trace on the three tests used ( Figure 1 ).
- composition C1 was compared with that of Anisoyme® DLM Maxi (Laboratoires Anios, Hellemmes, France), a trienzymatic detergent containing a protease, a lipase, an amylase and the chelating agent EDTA.
- the on-board test used was the TOSI AMCOR (reference 35002577).
- composition according to the invention allows more effective cleaning at low temperatures and dosages. This is all the more surprising since the chelating activity of EDTA is at the base superior to that of MGDA which would allow waiting for a superior cleaning efficiency for Aniosyme® DLM Maxi.
- composition C1 The respective stabilities of subtilisin, lipase and amylase in composition C1 were evaluated by the following tests.
- subtilisin contained in the detergent is followed by the technique of electrophoresis on polyacrylamide gel, the substrate used is a solution of human serum albumin at 0.3% (soiling representative of an application in health care establishment ).
- the Figure 2 shows four tracks of electrophoresis: track 1 corresponds to the control (human albumin serum (0.3%) not degraded), tracks 2, 3 and 4 to composition C1 after manufacture, 3 weeks of storage in a hermetically closed container at 30 ° C and 7 weeks of storage in a tightly closed container at 30 ° C respectively. It is noted that the enzymatic activity of subtilisin does not degrade for at least 7 weeks.
- the activity of the lipase was followed by the technique of thin layer chromatography (TLC), the substrate used is a triglyceride and the eluent a mixture of 50 ml of heptane, 20 ml of diethyl ether, 0 , 5 mL of acetic acid and 1.5 mL of ethanol.
- TLC thin layer chromatography
- Lipase degrading triglycerides the absence of triglycerides, and the presence of diglycerides and monglycerides highlights the enzymatic activity of lipase.
- the Figure 3 shows six tracks of CCM: tracks 1, 2, 3 correspond to the controls (1: triglycerides, 2: diglycerides, 3: monoglycerides), tracks 4, 5 and 6 with composition C1 after manufacture, after 3 weeks of storage in a tightly closed container at 30 ° C and after 7 weeks of storage in a tightly closed container at 30 ° C respectively. It is noted that the enzymatic activity of the lipase does not degrade for at least 7 weeks.
- the activity of the amylase was followed by the technique of thin layer chromatography (TLC), the substrate used is glycogen and the eluent a mixture of 70 ml of ethanol, 1 ml of acetic acid and 29 mL of demineralized water.
- TLC thin layer chromatography
- Amylase degrading glycogen, the absence of glycogen and the presence of glucose demonstrate the enzymatic activity of amylase.
- the Figure 4 shows five tracks of CCM: tracks 1 and 2 correspond to the controls (1: glycogen, 2: glucose), tracks 3, 4 and 5 to composition C1 after manufacture, after 3 weeks of storage in a container hermetically closed at 30 ° C and after 7 weeks of storage in a tightly closed container at 30 ° C respectively. It is noted that the enzymatic activity of amylase does not degrade for at least 7 weeks.
- composition C1 The influence of the presence of the three enzymes subtilisin, lipase and amylase in the detergent composition was evaluated by comparing composition C1 with compositions without enzymes (C4), with subtilisin (C5) and with lipase and amylase (C6).
- the degreasing cleaning power of the various compositions was evaluated with respect to English soiling according to ISO standard 15883 which was applied with a brush on stainless steel blades (one blade per composition tested) and left to dry for one hour at ambient temperature. Then each blade was soaked with stirring (three-dimensional agitator, 50 rpm) for 15 min at room temperature in one of the four detergent compositions diluted to 0.3% (v / v) in softened water (5 ° f).
- composition C1 The slides treated with compositions C4, C5 and C6 indeed showed significant residues of English soiling visible to the naked eye.
- the determination of residual proteins by the MicroBCA technique confirms these observations.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Detergent Compositions (AREA)
Description
La présente invention concerne l'utilisation de compositions détergentes enzymatiques pour le nettoyage automatique d'instruments et/ou appareils chirurgicaux et/ou médicaux.The present invention relates to the use of enzymatic detergent compositions for the automatic cleaning of surgical and / or medical instruments and / or apparatus.
En milieu hospitalier, les instruments chirurgicaux sont en général soumis à un nettoyage automatique en laveur désinfecteur d'instruments (LDI) en utilisant des détergents fortement alcalins suivi d'une désinfection thermique ou chimique. Ces détergents ont généralement un pH supérieur à 12 ce qui les rends très corrosifs.In hospitals, surgical instruments are generally subjected to automatic cleaning in a washer-disinfector of instruments (LDI) using strongly alkaline detergents followed by thermal or chemical disinfection. These detergents generally have a pH higher than 12 which makes them very corrosive.
Pour éviter les dommages causés par ces détergents alcalins, des détergents enzymatiques ont été proposés. On connaît par exemple le MEDICLEAN® forte de Dr. Weigert qui fait d'ailleurs l'objet du brevet européen
C'est pourquoi Dr. Weigert a développé le neodisher® SYSTEM ALPHA qui est composé de deux composantes très concentrés distinctes, à savoir une composante enzymatique, le neodisher® SystemAct, et une composante alcaline, le neodisher® SystemClean. La composante enzymatique contient une subtilisine tandis que la composante alcaline contient de la triéthanolamine et de l'acide méthylglycine diacétique (MGDA). Ce système fait d'ailleurs l'objet de la demande de brevet internationale
Même si ce système permet de résoudre les problèmes liés à l'instabilité de l'enzyme en présence de fortes concentrations d'agents alcalins comme les alcanolamines, il présente un désavantage majeur en ce qu'il nécessite un équipement spécifique pour pouvoir alimenter le laveur désinfecteur d'instruments avec les deux composantes simultanément. Les laveurs désinfecteurs d'instruments ne possèdent en effet qu'une alimentation de composition détergente.Even if this system makes it possible to solve the problems linked to the instability of the enzyme in the presence of high concentrations of alkaline agents such as alkanolamines, it has a major disadvantage in that it requires specific equipment to be able to feed the instrument washer-disinfector with the two components simultaneously. Instrument washer-disinfectors only have a supply of detergent composition.
Le brevet
Il existe donc toujours un besoin d'un moyen pour nettoyer efficacement les instruments chirurgicaux et médicaux en machine sans présenter les problèmes de stabilité des solutions proposées dans l'état de la technique et sans nécessiter un appareillage spécifique pour pouvoir alimenter les machines utilisées pour le nettoyage.There is therefore always a need for a means for effectively cleaning surgical and medical instruments in a machine without presenting the problems of stability of the solutions proposed in the prior art and without requiring specific apparatus in order to be able to supply the machines used for the cleaning.
Il est du mérite de la Demanderesse d'avoir trouvé au fruit de nombreuses recherches que ces inconvénients pouvaient être palliés en utilisant une composition détergente concentrée qui repose sur la combinaison de trois enzymes et d'un agent chélatant puissant et qui ne contient pas d'alcanolamine.It is to the credit of the Applicant to have found in the fruit of numerous researches that these drawbacks could be overcome by using a concentrated detergent composition which is based on the combination of three enzymes and a powerful chelating agent and which does not contain any alkanolamine.
L'invention concerne donc l'utilisation d'une composition détergente aqueuse concentrée pour le nettoyage d'instruments chirurgicaux et/ou médicaux en laveur désinfecteur, ladite composition détergente aqueuse concentrée comprenant :
- une subtilisine,
- une lipase,
- une amylase,
- un agent chélatant biodégradable choisi parmi l'acide méthylglycine diacétique (MGDA) et un iminodisuccinate (IDS) et
- de l'eau,
- a subtilisin,
- lipase,
- an amylase,
- a biodegradable chelating agent chosen from acid diacetic methylglycine (MGDA) and an iminodisuccinate (IDS) and
- some water,
De façon tout à fait surprenante, cette combinaison spécifique d'une subtilisine, d'une lipase et d'une amylase avec du MGDA ou de l'IDS permet de s'affranchir de la nécessité de l'ajout d'alcanolamine tout en maintenant un nettoyage efficace d'instruments chirurgicaux et/ou médicaux souillés en laveur désinfecteur. Ainsi, la composition détergente aqueuse concentrée de l'invention ne présente pas les problèmes de stabilité enzymatique rencontrés dans les compositions enzymatiques de l'art antérieur contenant des alcanolamines.Surprisingly, this specific combination of a subtilisin, a lipase and an amylase with MGDA or IDS eliminates the need for adding alkanolamine while maintaining effective cleaning of soiled surgical and / or medical instruments in a washer-disinfector. Thus, the concentrated aqueous detergent composition of the invention does not present the problems of enzymatic stability encountered in the enzymatic compositions of the prior art containing alkanolamines.
De plus, étant donné que les principaux composants des tissus biologiques qui constituent des souillures majeures des instruments chirurgicaux et médicaux sont protéines, lipides (triglycérides) et polymères glucidiques (glycogène), le cocktail tri-enzymatique de la composition détergente aqueuse concentrée de l'invention hydrolysera simultanément les trois cibles et donc en facilitera la détergence.In addition, since the main components of biological tissues that constitute major stains in surgical and medical instruments are proteins, lipids (triglycerides) and carbohydrate polymers (glycogen), the tri-enzymatic cocktail of the concentrated aqueous detergent composition of the invention will simultaneously hydrolyze the three targets and thus facilitate detergency.
De plus, l'absence d'alcanolamine permet de formuler la composition détergente utilisée conformément à l'invention de façon très concentrée. Ainsi, la teneur en eau de la composition détergente aqueuse concentrée peut être réduite jusqu'à 25 % en poids par rapport au poids total de composition sans pour autant devoir ajouter de quantités importantes de tiers-solvant, impacter la stabilité des enzymes et nuire à l'efficacité de nettoyage.In addition, the absence of alkanolamine makes it possible to formulate the detergent composition used in accordance with the invention in a very concentrated manner. Thus, the water content of the concentrated aqueous detergent composition can be reduced up to 25% by weight relative to the total weight of the composition without having to add significant amounts of third-solvent, impact the stability of the enzymes and harm cleaning efficiency.
La composition utilisée conformément à l'invention a avantageusement une teneur en subtilisine de 0,5 à 15% en poids par rapport au poids total de la composition, de préférence de 1 à 10% en poids par rapport au poids total de la composition, de préférence de 1 à 5% en poids par rapport au poids total de la composition, plus préférentiellement d'environ 3% en poids par rapport au poids total de la composition. La teneur en lipase est avantageusement de 0,05 à 2% en poids par rapport au poids total de la composition, de préférence de 0,5 à 1,5% en poids par rapport au poids total de la composition, plus préférentiellement d'environ 1% en poids par rapport au poids total de la composition. La teneur en amylase est avantageusement de 0,05 à 2% en poids par rapport au poids total de la composition, de préférence de 0,5 à 1,5% en poids par rapport au poids total de la composition, plus préférentiellement d'environ 1% en poids par rapport au poids total de la composition.The composition used in accordance with the invention advantageously has a subtilisin content of 0.5 to 15% by weight relative to the total weight of the composition, preferably from 1 to 10% by weight relative to the total weight of the composition, preferably from 1 to 5% by weight relative to the total weight of the composition, more preferably around 3% by weight. relative to the total weight of the composition. The lipase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition. The amylase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.
L'agent chélatant biodégradable est choisi parmi l'acide méthylglycine diacétique (MGDA) et un iminodisuccinate (IDS), notamment l'iminodisuccinate tétrasodique. De préférence, l'agent chélatant biodégradable est de l'acide méthylglycine diacétique (MGDA). Sans vouloir être lié par une quelconque théorie, les inventeurs pensent que l'agent chélatant mis en œuvre dans la présente invention ne sert pas uniquement à l'adoucissement de l'eau mais aussi à complexer de manière particulièrement efficace des ions métalliques bi- et trivalents, notamment Ca2+, Fe3+, Fe2+ et Cu2+, contenus dans les résidus protéiques retrouvés typiquement sur les instruments chirurgicaux et/ou médicaux. Il semblerait que ces agents chélatants séquestrent ces ions métalliques ce qui déstabilise la structure tertiaire des protéines et les rends plus facilement hydrolysables.The biodegradable chelating agent is chosen from methylglycine diacetic acid (MGDA) and an iminodisuccinate (IDS), in particular the tetrasodium iminodisuccinate. Preferably, the biodegradable chelating agent is methylglycine diacetic acid (MGDA). Without wishing to be bound by any theory, the inventors believe that the chelating agent used in the present invention is not only used for softening water but also for complexing in a particularly effective way metal ions bi- and trivalent, in particular Ca 2+ , Fe 3+ , Fe 2+ and Cu 2+ , contained in the protein residues typically found on surgical and / or medical instruments. These chelating agents seem to sequester these metal ions, which destabilizes the tertiary structure of proteins and makes them more easily hydrolyzable.
La composition utilisée conformément à l'invention a avantageusement une teneur en agent chélatant biodégradable de 10 à 50% en poids par rapport au poids total de la composition, de préférence de 20 à 40% en poids par rapport au poids total de la composition, plus préférentiellement de 25 à 35% en poids par rapport au poids total de la composition, plus préférentiellement encore d'environ 30% en poids par rapport au poids total de la composition.The composition used in accordance with the invention advantageously has a content of biodegradable chelating agent of 10 to 50% by weight relative to the total weight of the composition, preferably from 20 to 40% by weight relative to the total weight of the composition, more preferably from 25 to 35% by weight relative to the total weight of the composition, more preferably still around 30% by weight relative to the total weight of the composition.
La composition détergente aqueuse concentrée est avantageusement exempte de tout agent chélatant non bio-dégradable, notamment d'acide éthylène-diamine-tétraacétique (EDTA), acide diéthylène-triamine-pentaacétique (DTPA), phosphates et polyphosphates. Avantageusement, la composition détergente aqueuse concentrée est également exempte de tout agent chélatant classé réprotoxique tel que l'acide nitrilotriacétique et son sel de sodium (NTA).The concentrated aqueous detergent composition is advantageously free from any non-biodegradable chelating agent, in particular ethylene-diamine-tetraacetic acid (EDTA), diethylene-triamine-pentaacetic acid. (DTPA), phosphates and polyphosphates. Advantageously, the concentrated aqueous detergent composition is also free from any chelating agent classified as reprotoxic such as nitrilotriacetic acid and its sodium salt (NTA).
Dans un mode de réalisation, la composition détergente aqueuse concentrée est également exempte d'hydroxydes alcalins et alcalinoterreux.In one embodiment, the concentrated aqueous detergent composition is also free from alkali and alkaline earth hydroxides.
La teneur en eau de la composition détergente concentrée utilisée conformément à l'invention est avantageusement de 10 à 50 % en poids par rapport au poids total de la composition, de préférence de 15 à 45 % en poids par rapport au poids total de la composition, plus préférentiellement de 20 à 40 % en poids par rapport au poids total de la composition et plus préférentiellement encore de 25 à 40% en poids par rapport au poids total de la composition. En plus de l'eau, la composition détergente concentrée peut également contenir un tiers-solvant tel un polyol. Des exemples de polyols appropriés comprennent notamment les alkylènes glycols tels que l'éthylène glycol, le propylène glycol et la glycérine (1,2,3-propanetriol). De préférence, le tiers-solvant est la glycérine. La glycérine a l'avantage de ne pas servir uniquement de tiers-solvant mais de stabiliser également les enzymes.The water content of the concentrated detergent composition used in accordance with the invention is advantageously from 10 to 50% by weight relative to the total weight of the composition, preferably from 15 to 45% by weight relative to the total weight of the composition , more preferably from 20 to 40% by weight relative to the total weight of the composition and more preferably still from 25 to 40% by weight relative to the total weight of the composition. In addition to water, the concentrated detergent composition may also contain a third solvent such as a polyol. Examples of suitable polyols include alkylene glycols such as ethylene glycol, propylene glycol and glycerin (1,2,3-propanetriol). Preferably, the third solvent is glycerin. Glycerin has the advantage of not only serving as a third solvent but also of stabilizing the enzymes.
La teneur en tiers-solvant est avantageusement de 5 à 50 % en poids par rapport au poids total de la composition, de préférence de 10 à 40 % en poids par rapport au poids total de la composition, plus préférentiellement de 13 à 25 % en poids par rapport au poids total de la composition.The content of third-solvent is advantageously from 5 to 50% by weight relative to the total weight of the composition, preferably from 10 to 40% by weight relative to the total weight of the composition, more preferably from 13 to 25% by weight. weight relative to the total weight of the composition.
La composition détergente concentrée utilisée conformément à l'invention peut en outre comprendre un ou plusieurs tensioactifs non ioniques. Le ou les agents tensioactifs non ioniques peuvent notamment être choisis parmi les tensioactifs non ioniques alcoxylés et les alkylpolyglucosides. Les tensioactifs non ioniques alcoxylés sont avantageusement choisis parmi les tensioactifs non ioniques alcoxylés, notamment parmi les alcools gras alcoxylés, notamment éthoxylés et/ou propoxylés, et les copolymères blocs EO-PO. Dans un mode de réalisation préféré, le ou les agents tensioactifs non ioniques sont choisis parmi les alkylpolyglucosides, de préférence il s'agit d'un alkylpolyglucoside en C7. Cet alkylpolyglucoside apporte en effet le triple avantage de jouer un rôle de stabilisant, d'apporter un effet mouillant favorable à la détergence et un caractère non-moussant compatible avec une application en laveur désinfecteur.The concentrated detergent composition used in accordance with the invention may also comprise one or more nonionic surfactants. The nonionic surfactant (s) may in particular be chosen from alkoxylated nonionic surfactants and alkylpolyglucosides. The alkoxylated nonionic surfactants are advantageously chosen from alkoxylated nonionic surfactants, in particular from alkoxylated fatty alcohols, in particular ethoxylated and / or propoxylated, and EO-PO block copolymers. In a preferred embodiment, the nonionic surfactant (s) are chosen from alkylpolyglucosides, preferably it is a C7 alkylpolyglucoside. This alkylpolyglucoside indeed brings the triple advantage of playing a stabilizing role, of bringing a wetting effect favorable to detergency and a non-foaming character compatible with an application in washer-disinfector.
La teneur en tensioactif non ionique dans la composition détergente utilisée conformément à l'invention est avantageusement de 1 à 10 %, de préférence de 2 à 5 %, plus préférentiellement d'environ 3 % en poids par rapport au poids total de la composition.The content of nonionic surfactant in the detergent composition used in accordance with the invention is advantageously from 1 to 10%, preferably from 2 to 5%, more preferably from approximately 3% by weight relative to the total weight of the composition.
La composition détergente utilisée conformément à l'invention peut en outre comprendre un acide ou un système de tampon pour ajuster le pH. De préférence, on ajoute un acide organique, choisi parmi les acides en C2-C6 mono-, di- et tricarboxyliques, notamment choisi parmi l'acide citrique, l'acide tartrique, l'acide malique, l'acide lactique, l'acide glutarique, l'acide gluconique l'acide glycolique, l'acide succinique et l'acide adipique. L'acide citrique est particulièrement préféré. Elle présente l'avantage de servir en même temps comme agent complexant comme également l'acide tartrique et l'acide gluconique.The detergent composition used in accordance with the invention may further comprise an acid or a buffer system for adjusting the pH. Preferably, an organic acid is added, chosen from C 2 -
Avantageusement, la composition ne contiendra pas d'agent antimicrobien, notamment pas d'aminé antimicrobienne, et n'aura donc aucune revendication d'activité antimicrobienne à la dose d'emploi. Celle-ci est à distinguer d'un effet bactériostatique qui par contre pourra être recherché. A cet effet, la composition détergente utilisée conformément à l'invention peut également comprendre un agent conservateur. L'agent conservateur peut être choisi parmi les agents conservateurs habituellement utilisés, comme par exemple le 5-chloro-5-méthyl-4-isothiazoline-3-one, le 2-méthyl-4-isothiazolin3-one, l'acide p-hydroxybenzoïque et ses esters de méthyl, le 5-bromo-5-nitro-1,3-dioxane et l'acide salicylique, l'alcool benzylique et le benzoate de sodium. Ces agents conservateurs permettent d'éviter une contamination microbienne et fongique en apportant un effet bactériostatique et fongistatique.Advantageously, the composition will not contain an antimicrobial agent, in particular no antimicrobial amine, and will therefore have no claim for antimicrobial activity at the dose of use. This is to be distinguished from a bacteriostatic effect which on the other hand can be sought. To this end, the detergent composition used in accordance with the invention may also comprise a preservative. The preservative can be chosen from the preservatives usually used, such as for example 5-chloro-5-methyl-4-isothiazoline-3-one, 2-methyl-4-isothiazolin3-one, p- acid hydroxybenzoic acid and its methyl esters, 5-bromo-5-nitro-1,3-dioxane and salicylic acid, benzyl alcohol and sodium benzoate. These preservatives prevent microbial and fungal contamination by bringing a bacteriostatic and fungistatic effect.
La composition détergente utilisée conformément à l'invention peut également comprendre un agent hydrotrope. Cet agent hydrotrope peut par exemple être choisi parmi les xylènesulfonates, les toluènesulfonates, les cumènes sulfonates, l'urée, le méthylacétamide, du polyéthylèneglycol et du polypropylèneglycol.The detergent composition used in accordance with the invention may also comprise a hydrotropic agent. This hydrotropic agent can for example be chosen from xylenesulfonates, toluenesulfonates, cumenesulfonates, urea, methylacetamide, polyethylene glycol and polypropylene glycol.
La composition détergente concentrée utilisée conformément à l'invention peut en outre comprendre d'autres adjuvants tels que par exemple des agents dispersants et/ou des agents anti-mousse. Les agents dispersants peuvent par exemple être des acides des homo-, co- ou terpolymères à base d'acide acrylique ou des sels de métaux alcalins de ceux-ci (polyacrylates).The concentrated detergent composition used in accordance with the invention may also comprise other adjuvants such as, for example, dispersing agents and / or anti-foaming agents. The dispersing agents can for example be acids of homo-, co- or terpolymers based on acrylic acid or alkali metal salts thereof (polyacrylates).
Dans l'utilisation selon l'invention, la composition détergente est mise en œuvre dans un laveur désinfecteur (LD) tel qu'un laveur désinfecteur d'instruments (LDI) ou un laveur désinfecteur d'endoscope (LDE). Le terme « laveur désinfecteur » est à comprendre tel qu'il est défini dans la norme ISO 15883-1 :2006, à savoir une machine destinée à nettoyer et désinfecter des dispositifs médicaux et tous les autres articles utilisés dans les milieux médical, dentaire, pharmaceutique et vétérinaire. Aussi, le terme « instruments chirurgicaux et/ou médicaux » tels qu'utilisé dans la présente demande est à comprendre de façon large comme désignant les dispositifs médicaux et tous les autres articles utilisés dans les milieux médical, dentaire, pharmaceutique et vétérinaire nécessitant un nettoyage avec des détergents aqueux avant réutilisation.In the use according to the invention, the detergent composition is used in a washer-disinfector (LD) such as a washer-disinfector of instruments (LDI) or a washer-disinfector of endoscope (LDE). The term "washer-disinfector" should be understood as defined in standard ISO 15883-1: 2006, namely a machine intended for cleaning and disinfecting medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary. Also, the term "surgical and / or medical instruments" as used in the present application is to be understood broadly as designating medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary environments requiring cleaning. with aqueous detergents before reuse.
Dans la présente invention, ce nettoyage est avantageusement mise en œuvre à une température de 20 à 60 °C, de préférence de 45 à 55 °C, plus préférentiellement de 50 à 55 °C. La durée de nettoyage est avantageusement comprise entre 20 s et 10 min, de préférence entre 30 s et 5 min.In the present invention, this cleaning is advantageously carried out at a temperature of 20 to 60 ° C., preferably from 45 to 55 ° C., more preferably from 50 to 55 ° C. The cleaning time is advantageously between 20 s and 10 min, preferably between 30 s and 5 min.
La présente invention porte également sur la composition détergente aqueuse concentrée mise en œuvre dans l'utilisation selon l'invention telle que décrite ci-dessus. Cette composition est à diluer avec de l'eau, préférentiellement adoucie, déminéralisée ou osmosée, avant emploi. La dilution est généralement de 0,03% à 1% (v/v), de préférence de 0,1% à 0.6% (v/v), plus préférentiellement de 0,2 à 0,4% (v/v). Le pH de la composition diluée prête à l'emploi est avantageusement de 8 à 11, de préférence de 8,5 à 9,5, plus préférentiellement de 8,8 à 9,2 et plus préférentiellement encore d'environ 9. Pour la détermination du pH de la composition diluée, de l'eau adoucie est utilisée (degré de dureté d'environ 5°f).The present invention also relates to the concentrated aqueous detergent composition used in the use according to the invention as described above. This composition is to be diluted with water, preferably softened, demineralized or osmosis, before use. The dilution is generally from 0.03% to 1% (v / v), preferably from 0.1% to 0.6% (v / v), more preferably from 0.2 to 0.4% (v / v) . The pH of the ready-to-use diluted composition is advantageously from 8 to 11, preferably from 8.5 to 9.5, more preferably from 8.8 to 9.2 and even more preferably from approximately 9. For the determination of the pH of the diluted composition, softened water is used (degree of hardness of approximately 5 ° f).
L'invention sera maintenant décrite à l'aide d'exemples non limitatifs de réalisation de l'invention.The invention will now be described with the aid of nonlimiting examples of embodiment of the invention.
-
Figure 1 : Photos des tests de détergence embarqué pour les compositions C1, C2 et C3.Figure 1 : Photos of on-board detergency tests for compositions C1, C2 and C3. -
Figure 2 : Evaluation de l'activité de la subtilisine par électrophorèse sur gel.Figure 2 : Evaluation of the activity of subtilisin by gel electrophoresis. -
Figure 3 : Evaluation de l'activité de la lipase par chromatographie sur couche mince.Figure 3 : Evaluation of the activity of lipase by thin layer chromatography. -
Figure 4 : Evaluation de l'activité de l'amylase par chromatographie sur couche mince.Figure 4 : Evaluation of the activity of amylase by thin layer chromatography.
Les trois compositions détergentes concentrées suivantes (tableau 1) ont été évaluées pour leur capacité à nettoyer efficacement des résidus typiquement retrouvé sur des instruments chirurgicaux et médicaux.
- Injection du détergent à 35°C, dilution de 0,3% (v/v) en eau adoucieInjection of detergent at 35 ° C, dilution of 0.3% (v / v) in softened water
- Lavage avec de l'eau adoucie pendant 3mn à 55°CWash with softened water for 3 minutes at 55 ° C
- Rinçage avec de l'eau de réseau froideRinse with cold tap water
- SéchageDrying
- Simicon (SIMICON PET-K-10 de SIMICON GmbH, Munich, Allemagne)Simicon (SIMICON PET-K-10 from SIMICON GmbH, Munich, Germany)
- Wash check H (Getinge, Sweden)Wash check H (Getinge, Sweden)
- Load Check Browne (Steris, USA)Load Check Browne (Steris, USA)
Les différents tests ont été utilisés selon les modes d'emplois fournit par le fabricant respectif.The different tests were used according to the instructions for use provided by the respective manufacturer.
Les essais de performance ont montré que les trois compositions C1, C2 et C3 donnent des résultats tout à fait satisfaisants dans les conditions de tests. Les meilleurs résultats sont toutefois obtenus avec la composition C1. Avec cette composition, on ne détecte en effet aucune trace sur les trois tests utilisés (
Les essais ont été répétés à une température de nettoyage de 40°C et une dilution des compositions à 0,5 % (v/v). Les résultats obtenus sont comparables à ceux obtenus à 40°C et confirment donc l'efficacité des compositions selon l'invention.The tests were repeated at a cleaning temperature of 40 ° C and a dilution of the compositions to 0.5% (v / v). The results obtained are comparable to those obtained at 40 ° C and therefore confirm the effectiveness of the compositions according to the invention.
La performance de la composition C1 a été comparée à celle de l'Anisoyme ® DLM Maxi (Laboratoires Anios, Hellemmes, France), un détergent trienzymatique contenant une protéase, une lipase, une amylase et l'agent chélatant EDTA. Le test embarqué utilisé était le TOSI AMCOR (référence 35002577).The performance of composition C1 was compared with that of Anisoyme® DLM Maxi (Laboratoires Anios, Hellemmes, France), a trienzymatic detergent containing a protease, a lipase, an amylase and the chelating agent EDTA. The on-board test used was the TOSI AMCOR (reference 35002577).
Pour chaque essai, le cycle de traitement se déroule comme suit :
- Prélavage : eau de réseau froide, 1 min,
- Lavage : eau adoucie (5°f), 5 min, température et
dosage selon tableau 2 ci-dessous, - Rinçage : eau de réseau froide, 1 min,
- Rinçage final : eau osmosée à 90°C, 1 min avec de l'Anios RDA à 0,05 % (v/v).
- Prewash: cold mains water, 1 min,
- Washing: softened water (5 ° f), 5 min, temperature and dosage according to table 2 below,
- Rinsing: cold mains water, 1 min,
- Final rinse: osmosis water at 90 ° C, 1 min with 0.05% (v / v) Anios RDA.
Le tableau 2 ci-dessous récapitule les conditions d'essais et les résultats.
Ces essais montrent que la composition selon l'invention permet un nettoyage plus efficace à des températures et dosage faibles. Ceci est d'autant plus surprenant que l'activité chélatant de l'EDTA est à la base supérieure à celle du MGDA ce qui laisserait attendre une efficacité de nettoyage supérieure pour l'Aniosyme® DLM Maxi.These tests show that the composition according to the invention allows more effective cleaning at low temperatures and dosages. This is all the more surprising since the chelating activity of EDTA is at the base superior to that of MGDA which would allow waiting for a superior cleaning efficiency for Aniosyme® DLM Maxi.
Les stabilités respectives de la subtilisine, de la lipase et de l'amylase dans la composition C1 ont été évaluées par les tests suivants.The respective stabilities of subtilisin, lipase and amylase in composition C1 were evaluated by the following tests.
L'activité de la subtilisine contenue dans le détergent est suivie par la technique de l'électrophorèse sur gel de polyacrylamide, le substrat utilisé est une solution de sérum albumine humaine à 0,3% (salissure représentative d'une application en établissement de santé).The activity of the subtilisin contained in the detergent is followed by the technique of electrophoresis on polyacrylamide gel, the substrate used is a solution of human serum albumin at 0.3% (soiling representative of an application in health care establishment ).
Après migration, les protéines et peptides sont révélés par exposition dans une solution colorante au bleu de Coomassie suivie d'une décoloration. Une révélation au bleu de Coomassie permet de révéler les produits de dégradation issus de l'hydrolyse du sérum albumine humaine.After migration, the proteins and peptides are revealed by exposure in a staining solution with Coomassie blue followed by discoloration. A revelation with Coomassie blue reveals the degradation products resulting from the hydrolysis of human albumin serum.
La
L'activité de la lipase a été suivie par la technique de Chromatographie sur Couche Mince (CCM), le substrat utilisé est un triglycéride et l'éluant un mélange de 50 mL d'heptane, de 20 mL d'éther diéthylique, de 0,5 mL d'acide acétique et de 1.5mL d'éthanol.The activity of the lipase was followed by the technique of thin layer chromatography (TLC), the substrate used is a triglyceride and the eluent a mixture of 50 ml of heptane, 20 ml of diethyl ether, 0 , 5 mL of acetic acid and 1.5 mL of ethanol.
La lipase dégradant les triglycérides, l'absence de triglycérides, et la présence de diglycérides et de monglycérides met en évidence l'activité enzymatique de la lipase.Lipase degrading triglycerides, the absence of triglycerides, and the presence of diglycerides and monglycerides highlights the enzymatic activity of lipase.
La
L'activité de l'amylase a été suivie par la technique de Chromatographie sur Couche Mince (CCM), le substrat utilisé est du glycogène et l'éluant un mélange de 70 mL d'éthanol, de 1 mL d'acide acétique et de 29 mL d'eau déminéralisée.The activity of the amylase was followed by the technique of thin layer chromatography (TLC), the substrate used is glycogen and the eluent a mixture of 70 ml of ethanol, 1 ml of acetic acid and 29 mL of demineralized water.
L'amylase dégradant le glycogène, l'absence de glycogène et la présence de glucose mettent en évidence l'activité enzymatique de l'amylase.Amylase degrading glycogen, the absence of glycogen and the presence of glucose demonstrate the enzymatic activity of amylase.
La
L'influence de la présence des trois enzymes subtilisine, lipase et amylase dans la composition détergente a été évaluée en comparant la composition C1 à des compositions sans enzymes (C4), avec subtilisine (C5) et avec lipase et amylase (C6).
Pour ces essais le pouvoir nettoyant dégraissant des différentes compositions a été évalué par rapport à de la salissure anglaise selon la norme ISO 15883 qui a été appliquée au pinceau sur des lames en inox (une lame par composition testée) et laissée sécher pendant une heure à température ambiante. Ensuite chaque lame a été trempée sous agitation (agitateur tridimensionnel, 50 rpm) pendant 15 min à température ambiante dans l'une des quatre compositions détergente diluée à 0,3 % (v/v) dans de l'eau adoucie (5°f).For these tests, the degreasing cleaning power of the various compositions was evaluated with respect to English soiling according to ISO standard 15883 which was applied with a brush on stainless steel blades (one blade per composition tested) and left to dry for one hour at ambient temperature. Then each blade was soaked with stirring (three-dimensional agitator, 50 rpm) for 15 min at room temperature in one of the four detergent compositions diluted to 0.3% (v / v) in softened water (5 ° f).
Les meilleurs résultats ont été obtenus pour la composition C1. Les lames traitées avec les compositions C4, C5 et C6 présentaient en effet d'importants résidus de salissure anglaise visible à l'œil nu. Le dosage des protéines résiduelles par la technique MicroBCA (kit INTERCHIM UPTIMA MicroBC Assay, référence UP75860A) confirme ces observations.The best results have been obtained for composition C1. The slides treated with compositions C4, C5 and C6 indeed showed significant residues of English soiling visible to the naked eye. The determination of residual proteins by the MicroBCA technique (INTERCHIM UPTIMA MicroBC Assay kit, reference UP75860A) confirms these observations.
Claims (11)
- Concentrated aqueous detergent composition comprising:- a subtilisin,- a lipase,- an amylase,- a biodegradable chelating agent selected from methyl glycine diacetic acid and an iminodisuccinate, and- water,said concentrated detergent composition being free of alkanolamine.
- Detergent composition according to claim 1, characterized by the fact that it has a subtilisin content of between 0.5 and 15% by weight when compared to the total weight of the composition.
- Detergent composition according to claim 1 or 2, characterized by the fact that it has a lipase content of between 0.05 and 2% by weight when compared to the total weight of the composition.
- Detergent composition according to any one of the claims 1 through 3, characterized by the fact that it has an amylase content of between 0.05 and 2% by weight when compared to the total weight of the composition.
- Detergent composition according to any one of the claims 1 through 4, characterized by the fact that the biodegradable chelating agent is methyl glycine diacetic acid.
- Detergent composition according to any one of the claims 1 through 5, characterized by the fact that it has a biodegradable chelating agent content of between 10 and 50% by weight when compared to the total weight of the composition.
- Detergent composition according to any one of the claims 1 through 6, characterized by the fact that it likewise comprises glycerin.
- Detergent composition according to any one of the claims 1 through 7, characterized by the fact that it likewise comprises one or a plurality of non-ionic surfactants.
- Use of a concentrated aqueous detergent composition according to any one of the preceding claims for the cleaning of surgical and/or medical instruments in a washer-disinfector.
- Use according to claim 9, characterized by the fact that the cleaning is carried out at a temperature of between 20 and 60°C.
- Use according to claim 9 or 10, characterized by the fact that the cleaning time period is between 20 seconds and 10 minutes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL17716972T PL3433349T3 (en) | 2016-03-23 | 2017-03-23 | Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1652498A FR3049285B1 (en) | 2016-03-23 | 2016-03-23 | DETERGENT ENZYMATIC COMPOSITIONS FOR THE AUTOMATIC CLEANING OF SURGICAL AND / OR MEDICAL INSTRUMENTS AND / OR DEVICES. |
PCT/FR2017/050684 WO2017162991A1 (en) | 2016-03-23 | 2017-03-23 | Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3433349A1 EP3433349A1 (en) | 2019-01-30 |
EP3433349B1 true EP3433349B1 (en) | 2020-04-22 |
Family
ID=56263860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17716972.9A Active EP3433349B1 (en) | 2016-03-23 | 2017-03-23 | Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3433349B1 (en) |
FR (1) | FR3049285B1 (en) |
PL (1) | PL3433349T3 (en) |
WO (1) | WO2017162991A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741355B1 (en) * | 1995-11-17 | 1998-12-31 | Anios Lab Sarl | COMPOSITION FOR THE TREATMENT OF OBJECTS TO BE CLEANED AND / OR DISINFECTED |
US7491362B1 (en) * | 2008-01-28 | 2009-02-17 | Ecolab Inc. | Multiple enzyme cleaner for surgical instruments and endoscopes |
US7723281B1 (en) * | 2009-01-20 | 2010-05-25 | Ecolab Inc. | Stable aqueous antimicrobial enzyme compositions comprising a tertiary amine antimicrobial |
FR2980955B1 (en) * | 2011-10-05 | 2014-12-12 | Anios Lab Sarl | DISINFECTANT AND DETERGENT COMPOSITIONS. |
-
2016
- 2016-03-23 FR FR1652498A patent/FR3049285B1/en active Active
-
2017
- 2017-03-23 PL PL17716972T patent/PL3433349T3/en unknown
- 2017-03-23 WO PCT/FR2017/050684 patent/WO2017162991A1/en active Application Filing
- 2017-03-23 EP EP17716972.9A patent/EP3433349B1/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
EP3433349A1 (en) | 2019-01-30 |
FR3049285A1 (en) | 2017-09-29 |
FR3049285B1 (en) | 2018-04-13 |
PL3433349T3 (en) | 2020-10-19 |
WO2017162991A1 (en) | 2017-09-28 |
WO2017162991A9 (en) | 2018-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5407002B2 (en) | Cleaning composition for medical instrument washer | |
KR100978822B1 (en) | Anti-corrosion detergent compositions and use of same in cleaning dental and medical instruments | |
CN112292442B (en) | Enzyme detergent for pan | |
US20080271760A1 (en) | Method and Composition | |
JP2009149777A (en) | Detergent composition for dish washer and method for producing the same | |
US9133424B2 (en) | Stabilization and activation of protease for use at high temperature | |
JP6732454B2 (en) | Cleaning disinfectant composition | |
KR102001696B1 (en) | Liquid cleaning compositions with improved enzyme compatibility and/or stability | |
EP2588420B1 (en) | Descaling of oxalates with acid compositions | |
CN105907483A (en) | Oxygen-containing multifunctional detergent composition | |
KR101900978B1 (en) | Liquid cleaning agent composition | |
JP7315948B2 (en) | Disinfectant detergent composition | |
JP2001501244A (en) | Surface cleaner | |
JP2019104793A (en) | Liquid detergent composition | |
JP2009019130A (en) | Detergent composition and deterging method of dishes using the same | |
JP6864339B2 (en) | Cleaning agent composition for automatic washing machine | |
EP3433349B1 (en) | Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices | |
BE1027322B1 (en) | Cleaning and degreasing composition for the treatment of hard surfaces | |
CN110546248A (en) | Formulations and methods for cryogenic cleaning of dairy equipment | |
WO2022250123A1 (en) | Method for promoting enzymatic reaction | |
EP2970831B1 (en) | Enzyme-containing detergent and presoak composition and methods of using | |
EP3411464B1 (en) | Detergent compositions for cleaning in the cosmetic and pharmaceutical industry | |
JP3779062B2 (en) | Beer dispenser cleaning composition and cleaning method | |
WO2022270458A1 (en) | Dish washing method | |
FR3066376A1 (en) | WET DETERGENT WIPES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180924 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20191127 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017015228 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1260072 Country of ref document: AT Kind code of ref document: T Effective date: 20200515 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602017015228 Country of ref document: DE Representative=s name: GODEMEYER BLUM LENZE PATENTANWAELTE, PARTNERSC, DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200822 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200723 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200824 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1260072 Country of ref document: AT Kind code of ref document: T Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017015228 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20210125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210323 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210323 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170323 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20231229 Year of fee payment: 8 Ref country code: GB Payment date: 20240108 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20240119 Year of fee payment: 8 Ref country code: IT Payment date: 20240212 Year of fee payment: 8 Ref country code: FR Payment date: 20240103 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |